DURAClone IF Basophil Activation Citations
The following scientific literature references describe clinical research uses of of the listed products for immunological biomarker assessment and discovery purposes. These products are for research use only and are not labeled for diagnostic use.
Pollen/Fruit Syndrome: Clinical Relevance of the Cypress Pollen Allergenic Gibberellin-Regulated ProteinHélène Sénéchal, Sanaz Keykhosravi, Rémy Couderc, Marie-Ange Selva, Youcef Shahali, Tomoyasu Aizawa, Jean-Marc Busnel, Rihane Arif, Inna Mercier, Nhan Pham-Thi, Denis-André Charpin, Pascal Poncet. Allergy Asthma Immunol Res. 2019 Jan; 11(1): 143–151.
- DURAClone IF Basophil Activation, Part Number C23406